Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01246
|
|||||
Drug Name |
Succinate
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Dietary supplements [ICD11: 5B7Z] | Investigative | ||||
Formula |
C4H4O4-2
|
|||||
Canonical SMILES |
C(CC(=O)[O-])C(=O)[O-]
|
|||||
InChI |
InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2
|
|||||
InChIKey |
KDYFGRWQOYBRFD-UHFFFAOYSA-L
|
|||||
CAS Number |
CAS 56-14-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 116.07 | Topological Polar Surface Area | 80.3 | ||
Heavy Atom Count | 8 | Rotatable Bond Count | 1 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
0.7
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:30031
|
|||||
DT(s) Transporting This Drug | NaCT | Transporter Info | Sodium-coupled citrate transporter | Substrate | [1] | |
NADC3 | Transporter Info | Sodium/dicarboxylate cotransporter 3 | Substrate | [2] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | NADC3 | Transporter Info | Km = 112 microM | HEK293T cells-NADC3 | [2] | |
References | ||||||
1 | SLC13 family of Na+ coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):299-312. | |||||
2 | SLC13A3 variants cause acute reversible leukoencephalopathy and -ketoglutarate accumulation. Ann Neurol. 2019 Mar;85(3):385-395. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.